Fate Therapeutics, Inc. (FATE)
Nasdaq: FATE · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2008
The company now
Fate Therapeutics, Inc. is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836), based in San Diego, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $6.6 million and a loss of $136 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.